Skip to main content

Table 2 Clinical characteristics of HIV positive perinatal women in Gondar town health institutions, Northwest Ethiopia, 2019 (N = 414)

From: Prevalence of suicidal ideation and associated factors among HIV positive perinatal women on follow-up at Gondar town health institutions, Northwest Ethiopia: a cross-sectional study

Characteristics

Category

Frequency, n (%)

When do you know your HIV status

Before pregnancy

272 (65.7)

After pregnancy

134(32.3)

Labor and delivery

1(0.2)

Post-partum period

7(1.8)

Duration of HIV illness in months

≤24

100(24.2)

25–48

62(15)

49–72

77(18.6)

≥73

175(42.3)

WHO stage

Stage 1

382(92.3)

Stage 2

32(7.7)

ART regimen

First line

383(92.5)

Second line

31(7.5)

ART regimen taking

TDF/3TC/EFV

232(56)

AZT/3TC/NVP

127(30.7)

TDF/3TC/NVP

20(4.8)

TDF/3TC/ATV/r

25(6)

AZT/3TC/EFV

8(2)

Other

2(0.5)

Partner HIV status

Positive

246(59.4)

Negative

62(15)

Unknown

106(25.6)

Disclosed HIV status

Yes

367(88.6)

No

47(11.4)

Comorbidities

Yes

130(31.4)

No

284(68.6)

Type of comorbidities

Diabetes mellitus

4(3)

Hypertension

2(1.5)

Tuberculosis

124(95.5)

CD4 count

< 200

56(13.5)

≥200

358(86.5)

Hemoglobin

< 12 mg/dl

178(43)

≥12 mg/dl

236(57)

Syphilis test result

Negative

387(93.5)

Positive

27(6.5)

Perinatal depression

Yes

159(38.4)

No

255(61.6)

  1. TDF Tenofovir, 3TC Lamivudine, EFV Enfavirenz, NVP Neverapin, AZT Zidovudine